Calcitriol Ointment 3 μg/g Is Safe and Effective Over 52 Weeks for the Treatment of Mild to Moderate Plaque Psoriasis

Article Type
Article
Changed
Thu, 12/15/2022 - 15:12
Display Headline
Calcitriol Ointment 3 μg/g Is Safe and Effective Over 52 Weeks for the Treatment of Mild to Moderate Plaque Psoriasis
Author(s)
Lebwohl M
Ortonne J-P
Andres P
Briantais P

Article PDF
083040205.pdf
Author and Disclosure Information

Lebwohl M, Ortonne J-P, Andres P, Briantais P

Issue
Cutis - 83(4)
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Page Number
205-212
Sections
Original Research
Clinical Topics & News
Author(s)
Lebwohl M
Ortonne J-P
Andres P
Briantais P
Author(s)
Lebwohl M
Ortonne J-P
Andres P
Briantais P
Author and Disclosure Information

Lebwohl M, Ortonne J-P, Andres P, Briantais P

Author and Disclosure Information

Lebwohl M, Ortonne J-P, Andres P, Briantais P

Article PDF
083040205.pdf
Article PDF
083040205.pdf

Issue
Cutis - 83(4)
Issue
Cutis - 83(4)
Page Number
205-212
Page Number
205-212
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Publications
Cutis
MDedge Dermatology
Psoriasis Collection
B-Cell Lymphoma ICYMI
Breast Cancer ICYMI
Topics
Psoriasis
Article Type
Article
Display Headline
Calcitriol Ointment 3 μg/g Is Safe and Effective Over 52 Weeks for the Treatment of Mild to Moderate Plaque Psoriasis
Display Headline
Calcitriol Ointment 3 μg/g Is Safe and Effective Over 52 Weeks for the Treatment of Mild to Moderate Plaque Psoriasis
Sections
Original Research
Clinical Topics & News
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Adapalene–Benzoyl Peroxide Once-Daily, Fixed-Dose Combination Gel for the Treatment of Acne Vulgaris: A Randomized, Bilateral (Split-Face), Dose-Assessment Study of Cutaneous Tolerability in Healthy Participants

Article Type
Article
Changed
Thu, 01/10/2019 - 12:14
Display Headline
Adapalene–Benzoyl Peroxide Once-Daily, Fixed-Dose Combination Gel for the Treatment of Acne Vulgaris: A Randomized, Bilateral (Split-Face), Dose-Assessment Study of Cutaneous Tolerability in Healthy Participants
Author(s)
Andres P
Pernin C
Poncet M

Article PDF
081030278.pdf
Author and Disclosure Information

Andres P, Pernin C, Poncet M

Issue
Cutis - 81(3)
Publications
Cutis
MDedge Dermatology
Topics
Acne
Page Number
278-284
Sections
Original Research
Author(s)
Andres P
Pernin C
Poncet M
Author(s)
Andres P
Pernin C
Poncet M
Author and Disclosure Information

Andres P, Pernin C, Poncet M

Author and Disclosure Information

Andres P, Pernin C, Poncet M

Article PDF
081030278.pdf
Article PDF
081030278.pdf

Issue
Cutis - 81(3)
Issue
Cutis - 81(3)
Page Number
278-284
Page Number
278-284
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Acne
Article Type
Article
Display Headline
Adapalene–Benzoyl Peroxide Once-Daily, Fixed-Dose Combination Gel for the Treatment of Acne Vulgaris: A Randomized, Bilateral (Split-Face), Dose-Assessment Study of Cutaneous Tolerability in Healthy Participants
Display Headline
Adapalene–Benzoyl Peroxide Once-Daily, Fixed-Dose Combination Gel for the Treatment of Acne Vulgaris: A Randomized, Bilateral (Split-Face), Dose-Assessment Study of Cutaneous Tolerability in Healthy Participants
Sections
Original Research
Article Source

PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Andres P